Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies.

Kaye WH, Frank GK, Bailer UF, Henry SE, Meltzer CC, Price JC, Mathis CA, Wagner A.

Physiol Behav. 2005 May 19;85(1):73-81. Review.

PMID:
15869768
2.

Brain imaging of serotonin after recovery from anorexia and bulimia nervosa.

Kaye WH, Bailer UF, Frank GK, Wagner A, Henry SE.

Physiol Behav. 2005 Sep 15;86(1-2):15-7. Review.

PMID:
16102788
3.

Neurotransmitter and imaging studies in anorexia nervosa: new targets for treatment.

Barbarich NC, Kaye WH, Jimerson D.

Curr Drug Targets CNS Neurol Disord. 2003 Feb;2(1):61-72. Review.

PMID:
12769813
4.

Neuroimaging studies in eating disorders.

Frank GK, Bailer UF, Henry S, Wagner A, Kaye WH.

CNS Spectr. 2004 Jul;9(7):539-48. Review.

PMID:
15208513
5.

Serotonin: imaging findings in eating disorders.

Bailer UF, Kaye WH.

Curr Top Behav Neurosci. 2011;6:59-79. doi: 10.1007/7854_2010_78. Review.

PMID:
21243470
6.

Neurobiology of anorexia and bulimia nervosa.

Kaye W.

Physiol Behav. 2008 Apr 22;94(1):121-35. doi: 10.1016/j.physbeh.2007.11.037. Epub 2007 Nov 29. Review.

7.

Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood.

Kaye WH, Weltzin TE.

J Clin Psychiatry. 1991 Dec;52 Suppl:41-8. Review.

PMID:
1752859
8.

Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.

Bailer UF, Price JC, Meltzer CC, Mathis CA, Frank GK, Weissfeld L, McConaha CW, Henry SE, Brooks-Achenbach S, Barbarich NC, Kaye WH.

Neuropsychopharmacology. 2004 Jun;29(6):1143-55.

9.

Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.

Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Weissfeld L, Mathis CA, Drevets WC, Wagner A, Hoge J, Ziolko SK, McConaha CW, Kaye WH.

Arch Gen Psychiatry. 2005 Sep;62(9):1032-41.

PMID:
16143735
10.

Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa.

Kaye W, Gendall K, Strober M.

Biol Psychiatry. 1998 Nov 1;44(9):825-38. Review.

PMID:
9807638
11.

Reduced 5-HT2A receptor binding after recovery from anorexia nervosa.

Frank GK, Kaye WH, Meltzer CC, Price JC, Greer P, McConaha C, Skovira K.

Biol Psychiatry. 2002 Nov 1;52(9):896-906.

PMID:
12399143
12.

Brain serotonin 1A receptor binding in bulimia nervosa.

Tiihonen J, Keski-Rahkonen A, Löppönen M, Muhonen M, Kajander J, Allonen T, Någren K, Hietala J, Rissanen A.

Biol Psychiatry. 2004 Apr 15;55(8):871-3.

PMID:
15050870
13.

A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa.

Bailer UF, Kaye WH.

Curr Drug Targets CNS Neurol Disord. 2003 Feb;2(1):53-9. Review.

PMID:
12769812
14.

Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.

Kaye WH, Greeno CG, Moss H, Fernstrom J, Fernstrom M, Lilenfeld LR, Weltzin TE, Mann JJ.

Arch Gen Psychiatry. 1998 Oct;55(10):927-35.

PMID:
9783564
15.

Orexigenic/anorexigenic signals in bulimia nervosa.

Takimoto Y, Inui A, Kumano H, Kuboki T.

Curr Mol Med. 2003 Jun;3(4):349-60. Review.

PMID:
12776990
16.

Neuroimaging in eating disorders.

Stamatakis EA, Hetherington MM.

Nutr Neurosci. 2003 Dec;6(6):325-34. Review.

PMID:
14744036
17.

Enhanced platelet serotonin 5-HT2A receptor binding in anorexia nervosa and bulimia nervosa.

Spigset O, Andersen T, Hägg S, Mjöndal T.

Eur Neuropsychopharmacol. 1999 Dec;9(6):469-73.

PMID:
10625113
18.

Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa.

Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Mathis CA, Wagner A, Thornton L, Hoge J, Ziolko SK, Becker CR, McConaha CW, Kaye WH.

Biol Psychiatry. 2007 May 1;61(9):1090-9. Epub 2007 Jan 22.

PMID:
17241616
19.

Research update on serotonin function in bulimia nervosa and anorexia nervosa.

Wolfe BE, Metzger E, Jimerson DC.

Psychopharmacol Bull. 1997;33(3):345-54. Review.

PMID:
9550877
20.

Supplemental Content

Support Center